Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.6
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Revenue:    
PCT products, services, other $ 221,569 $ 164,772
Grant revenue 149,168 140,889
Total revenue 370,737 305,661
Costs and expenses:    
Cost of PCT products and services 104,544 78,194
Research and development 246,458 271,611
Selling and marketing 193,900 238,092
General and administrative 550,859 682,346
Total operating costs and expenses 1,095,761 1,270,243
Operating loss (725,024) (964,582)
Other (expense) income:    
Interest (expense) income,net (8,900) (56,313)
Change in fair value of warrant derivative liability (45,445) (42,012)
Total other (expense) income (54,345) (98,325)
Net loss (779,369) (1,062,907)
Accrued dividends on convertible preferred stock (32,173) (24,414)
Deemed dividend on Series J convertible preferred stock (582,548)   
Net loss applicable to common shareholders $ (1,394,090) $ (1,087,321)
Net loss per share attributable to common stockholders - basic and diluted $ (0.11) $ (0.14)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 12,149,267 7,712,539